First-Line Treatment of Meningococcemia
The first-line treatment for meningococcemia is intravenous ceftriaxone 2g every 12 hours or cefotaxime 2g every 6 hours for 5 days in patients who have clinically recovered. 1
Antibiotic Options
First-Line Treatment
- Ceftriaxone: 2g IV every 12 hours 2, 1, 3
- Cefotaxime: 2g IV every 6 hours 2, 1
- Duration: 5 days (if patient has clinically recovered) 2, 1
Alternative Treatment
For Severe Beta-Lactam Allergies
Treatment Algorithm
Initial Assessment:
- Recognize clinical signs of meningococcemia (petechial/purpuric rash, fever, headache, neck stiffness)
- Obtain blood cultures before starting antibiotics if possible, but do not delay treatment
Start Empiric Treatment Immediately:
Once Neisseria meningitidis is Confirmed:
Special Considerations:
Important Clinical Considerations
Monitoring Response
- Assess clinical response within the first 24-48 hours 1
- If no improvement or clinical deterioration occurs, consider:
- Repeat lumbar puncture
- Evaluation for complications
- Assessment for antibiotic resistance 1
Prophylaxis for Close Contacts
Potential Pitfalls
- Delayed treatment: Meningococcemia is a medical emergency requiring immediate antibiotic therapy 5
- Inadequate prophylaxis: Failure to provide prophylaxis to close contacts increases risk of secondary cases 1
- Ciprofloxacin resistance: Be aware of emerging resistance patterns in your region 4
- Incomplete treatment: Ensure full course of antibiotics even if rapid clinical improvement occurs 2, 1
Outpatient Considerations
- Outpatient parenteral antibiotic therapy may be considered when:
- Patient is afebrile and clinically improving
- Has received 5 days of inpatient therapy and monitoring
- Has reliable intravenous access
- Can access medical advice/care 24 hours a day 1
By following this treatment algorithm and being aware of potential pitfalls, clinicians can effectively manage meningococcemia and improve patient outcomes.